The Role of Natural Products As Pcsk9 Modulators: A Review Publisher Pubmed



Khayatan D^{1, 2} ; Zare K³ ; Khanahmadi M^{1, 2} ; Momtaz S^{4, 5} ; Butler AE⁶ ; Jamialahmadi T^{7, 8} ; Almahmeed W⁹ ; Abdolghaffari AH^{1, 2} ; Sahebkar A^{10, 11, 12} Show Affiliations
Source: Phytotherapy Research Published:2024

Abstract

A variety of mechanisms and drugs have been shown to attenuate cardiovascular disease (CVD) onset and/or progression. Recent researchers have identified a potential role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in modulating lipid metabolism and reducing plasma low density lipoprotein (LDL) levels. PCSK9 is the central protein in the metabolism of LDL cholesterol (LDL-C) owing to its major function in LDL receptor (LDLR) degradation. Due to the close correlation of cardiovascular disease with lipid levels, many in vivo and in vitro investigations are currently underway studying the physiological role of PCSK9. Furthermore, many studies are actively investigating the mechanisms of various compounds that influence lipid associated-disorders and their associated cardiovascular diseases. PCSK9 inhibitors have been shown to have significant impact in the prevention of emerging cardiovascular diseases. Natural products can effectively be used as PCSK9 inhibitors to control lipid levels through various mechanisms. In this review, we evaluate the role of phytochemicals and natural products in the regulation of PCSK9, and their ability to prevent cardiovascular diseases. Moreover, we describe their mechanisms of action, which have not to date been delineated. © 2024 John Wiley & Sons Ltd.